A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL OF ORAL SELEGILINE HYDROCHLORIDE FOR SMOKING CESSATION IN NICOTINE DEPENDENT CIGARETTE SMOKERS
Αποθηκεύτηκε σε:
WEINBERGER, A.H., ET AL., A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL OF ORAL SELEGILINE HYDROCHLORIDE FOR SMOKING CESSATION IN NICOTINE DEPENDENT CIGARETTE SMOKERS. DRUG AND ALCOHOL DEPENDENCE, Vol. 107, no. 2-3 (2010), p. 188-195.
Ref.
166768
Τοποθεσία:
SIIS R.854 Archivo
Palabras clave:
Ceguera, Drogodependencias, Efectos, Fármacos, Nicotina, Tabaco, Tratamiento médico, EE.UU.
Ceguera, Drogodependencias, Efectos, Fármacos, Nicotina, Tabaco, Tratamiento médico, EE.UU.
Παρόμοια τεκμήρια: A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL OF ORAL SELEGILINE HYDROCHLORIDE FOR SMOKING CESSATION IN NICOTINE DEPENDENT CIGARETTE SMOKERS
- A RANDOMIZED CONTROLLED TRIAL OF ORAL SELEGILINE PLUS NICOTINE SKIN PATCH COMPARED WITH PLACEBO PLUS NICOTINE SKIN PATCH FOR SMOKING CESSATION
- EFFICACY OF A NICOTINE NASAL SPRAY IN SMOKING CESSATION: A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
- SMOKING REDUCTION PROMOTES SMOKING CESSATION: RESULTS FROM A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF NICOTINE GUM WITH 2-YEAR FOLLOW-UP
- DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SELEGILINE TRANSDERMAL SYSTEM (STS) FOR THE TREATMENT OF COCAINE DEPENDENCE
- DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUOXETINE IN SMOKING CESSATION TREATMENT INCLUDING NICOTINE PATCH AND COGNITIVE-BEHAVIORAL GROUP THERAPY
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL EVALUATION OF A NICOTINE SUBLINGUAL TABLET IN SMOKING CESSATION